|Bid||69.56 x 1000|
|Ask||71.99 x 900|
|Day's range||69.53 - 70.97|
|52-week range||48.78 - 76.47|
|Beta (3Y monthly)||0.81|
|PE ratio (TTM)||39.03|
|Earnings date||23 Oct 2019 - 28 Oct 2019|
|Forward dividend & yield||0.72 (1.04%)|
|1y target est||74.22|
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
OptimizeRx's (OPRX) second-quarter 2019 results are likely to benefit from increased sales of core financial and brand messaging products.
Cerner (CERN) Q2 results benefit from higher revenues, gains in Licensed software, Professional and Managed services units, and gross margin expansion.
The healthcare technology provider met its revenue guidance and beat its adjusted earnings guidance, thanks primarily to growth in its services business.
Cerner (CERN) delivered earnings and revenue surprises of 3.13% and -0.40%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Top-line growth and solid show by Population Health, Revenue Cycle and IT Works are likely to aid Cerner's (CERN) Q2 earnings. However, expected decline in bookings is likely to be a dampener.
Cerner (CERN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NextGen (NXGN) integrates Appriss Health prescription monitoring and tracking analytics into NextGen Office that is likely to enhance the former's EHR system.
Walgreens Boots' (WBA) Retail Pharmacy USA division gains traction from comparable prescription volume growth and a sturdy retail prescription market.
This long-range strategy will aid Boston Scientific (BSX) to deliver a solid financial footing across its MedSurg, Rhythm and Neuro plus Cardiovascular segments.
Teleflex (TFX) issued a statement saying consumers who own the tampered product should immediately discontinue use and return all affected products.
IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.